Earnings Call · Q3 FY2023·2023-11-04

Q3 23EPS +37.40%·Rev n/aQ2 23EPS -35.11%·Rev n/aQ1 23EPS -95.95%·Rev n/aQ4 22EPS -56.25%·Rev n/a⚠ consensus missing

GeneDx Holdings Corp. WGS

Sabrina Dunbar — Investor Relations or Communications

Katherine Stueland — President and Chief Executive Officer

Kevin Feeley — Chief Financial Officer

−30.3%1d on move date−31.0% vs SPY3d−31.1%5d−38.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WGS calls or request research access.

More WGS calls Browse calls Request research access